Sarepta Therapeutics, Inc. - Demonstração de Resultados (TTM)

Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
Demonstração de Resultados (TTM)

A Demonstração de Resultados de Sarepta Therapeutics, Inc. mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 600 646 702 766 835 876 933 976 1,003 1,105 1,243 1,403 1,505 1,640 1,902 2,233 2,482 2,414 2,198 2,184
Mudar (%) 7.58 8.72 9.10 9.06 4.89 6.50 4.57 2.84 10.12 12.52 12.87 7.25 8.99 15.95 17.42 11.11 -2.73 -8.93 -0.64
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 912 869 862 876 907 1,001 1,017 1,072 1,058 1,033 1,028 998 946 1,031 1,124 1,028 1,160 1,214 2,362 2,326
Mudar (%) -4.71 -0.76 1.60 3.54 10.38 1.60 5.41 -1.32 -2.39 -0.48 -2.89 -5.19 8.97 8.98 -8.55 12.92 4.61 94.58 -1.52
% da receita 151.92 134.57 122.83 114.38 108.59 114.27 109.01 109.88 105.44 93.45 82.66 71.12 62.87 62.86 59.08 46.01 46.76 50.29 107.43 106.49
Lucro Operacional Bruto -312 -223 -160 -110 -72 -125 -84 -96 -55 72 216 405 559 609 778 1,206 1,321 1,200 -163 -142
Mudar (%) -28.37 -28.20 -31.27 -34.87 74.22 -32.73 14.67 -43.42 -232.65 198.04 87.99 37.87 9.04 27.75 54.92 9.57 -9.18 -113.62 -13.33
% da receita -51.92 -34.57 -22.83 -14.38 -8.59 -14.27 -9.01 -9.88 -5.44 6.55 17.34 28.88 37.13 37.14 40.92 53.99 53.24 49.71 -7.43 -6.49
Vendas, Gerais e Administrativas 305 291 283 283 365 409 451 490 455 471 482 498 518 526 558 564 564 527 492 467
Mudar (%) -4.67 -2.75 0.25 28.93 11.95 10.37 8.61 -7.29 3.54 2.38 3.38 4.06 1.41 6.12 1.19 -0.16 -6.44 -6.75 -5.02
% da receita 50.81 45.02 40.27 37.00 43.74 46.69 48.38 50.25 45.30 42.59 38.76 35.50 34.44 32.05 29.33 25.28 22.71 21.85 22.37 21.38
P&D 756 756 756 -612
Mudar (%) 0.00 0.00
% da receita 33.86 30.47 31.33 -28.04
OpEx 1,217 1,160 1,145 1,160 1,273 1,411 1,469 1,563 1,513 1,504 1,511 1,498 1,467 1,559 1,684 2,351 2,482 2,500 2,856 2,183
Mudar (%) -4.69 -1.26 1.27 9.74 10.82 4.15 6.39 -3.19 -0.59 0.46 -0.86 -2.08 6.29 7.99 39.59 5.61 0.70 14.25 -23.56
% da receita 202.84 179.70 163.20 151.48 152.42 161.03 157.47 160.20 150.81 136.13 121.54 106.76 97.48 95.06 88.53 105.25 100.04 103.56 129.92 99.95
Lucro operacional -617 -515 -444 -394 -438 -535 -536 -587 -510 -399 -268 -95 38 81 218 -117 -1 -86 -658 1
Mudar (%) -16.63 -13.78 -11.13 11.05 22.13 0.28 9.55 -13.21 -21.68 -32.92 -64.59 -140.06 113.30 169.15 -153.75 -99.20 9,128.22 664.79 -100.16
% da receita -102.84 -79.70 -63.20 -51.48 -52.42 -61.03 -57.47 -60.20 -50.81 -36.13 -21.54 -6.76 2.52 4.94 11.47 -5.25 -0.04 -3.56 -29.92 0.05
Despesa com juros -64 -66 -64 -64 -64 -63 -53 -44 -33 -23 -22 -20 -19 -19 -18 -19 -19 -22 -38 -55
Mudar (%) 3.29 -4.05 0.23 0.31 -1.97 -14.95 -17.79 -24.68 -28.83 -6.20 -9.80 -1.97 -1.60 -3.96 1.83 2.11 13.84 75.19 45.12
% da receita -10.68 -10.26 -9.05 -8.31 -7.65 -7.15 -5.71 -4.49 -3.29 -2.12 -1.77 -1.41 -1.29 -1.17 -0.97 -0.84 -0.77 -0.90 -1.74 -2.53
Resultado líquido -634 -486 -419 -357 -507 -716 -703 -1,115 -908 -691 -536 17 47 122 235 -248 -58 -272 -713 65
Mudar (%) -23.38 -13.85 -14.86 42.09 41.37 -1.78 58.53 -18.61 -23.89 -22.42 -103.15 179.91 157.62 93.06 -205.59 -76.67 368.48 162.75 -109.12
% da receita -105.73 -75.30 -59.66 -46.56 -60.66 -81.76 -75.40 -114.30 -90.46 -62.52 -43.11 1.20 3.14 7.43 12.37 -11.12 -2.34 -11.25 -32.45 2.98

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
GB:0L35 US$ 16,30
IT:1SRPT € 14,06
US:SRPT US$ 15,75
DE:AB3A € 13,84
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista